skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lung cancer translational and emerging therapies
Lung cancer translational and emerging therapies
Material Type:
Livro 		Adicionar ao Meu Espaço

Lung cancer translational and emerging therapies

Kishan J Pandya; Julie R Brahmer; Manuel Hidalgo MD

New York Informa Healthcare c2007

Localização: FM - Fac. Medicina    (WF658 L983 2007 e.4 )(Acessar)

2
Models for the modern power grid
Models for the modern power grid
Material Type:
Artigo 		Adicionar ao Meu Espaço

Models for the modern power grid

Cardieri, Paulo, 1964- Universidade Estadual de Campinas (Unicamp); Universidade Estadual De Campinas

https://repositorio.unicamp.br/acervo/detalhe/1191204

2014

Acesso online

3
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer

Gobbo, Jessica ; Marcion, Guillaume ; Cordonnier, Marine ; Dias, Alexandre M M ; Pernet, Nicolas ; Hammann, Arlette ; Richaud, Sarah ; Mjahed, Hajare ; Isambert, Nicolas ; Clausse, Victor ; Rébé, Cédric ; Bertaut, Aurélie ; Goussot, Vincent ; Lirussi, Frédéric ; Ghiringhelli, François ; de Thonel, Aurélie ; Fumoleau, Pierre ; Seigneuric, Renaud ; Garrido, Carmen

JNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.djv330 [Periódico revisado por pares]

United States: Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
5
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Thatcher, Nick, Prof ; Hirsch, Fred R, Prof ; Luft, Alexander V, MD ; Szczesna, Aleksandra, MD ; Ciuleanu, Tudor E, Prof ; Dediu, Mircea, MD ; Ramlau, Rodryg, Prof ; Galiulin, Rinat K, MD ; Bálint, Beatrix, MD ; Losonczy, György, Prof ; Kazarnowicz, Andrzej, MD ; Park, Keunchil, MD ; Schumann, Christian, Prof ; Reck, Martin, MD ; Depenbrock, Henrik, MD ; Nanda, Shivani, MS ; Kruljac-Letunic, Anamarija, PhD ; Kurek, Raffael, MD ; Paz-Ares, Luis, MD ; Socinski, Mark A, Prof

The lancet oncology, 2015-07, Vol.16 (7), p.763-774 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Solomon, Benjamin J ; Mok, Tony ; Kim, Dong-Wan ; Wu, Yi-Long ; Nakagawa, Kazuhiko ; Mekhail, Tarek ; Felip, Enriqueta ; Cappuzzo, Federico ; Paolini, Jolanda ; Usari, Tiziana ; Iyer, Shrividya ; Reisman, Arlene ; Wilner, Keith D ; Tursi, Jennifer ; Blackhall, Fiona

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Butts, Charles, Dr ; Socinski, Mark A, Prof ; Mitchell, Paul L, MD ; Thatcher, Nick, Prof ; Havel, Libor, MD ; Krzakowski, Maciej, Prof ; Nawrocki, Sergiusz, MD ; Ciuleanu, Tudor-Eliade, MD ; Bosquée, Lionel, MD ; Trigo, José Manuel, MD ; Spira, Alexander, MD ; Tremblay, Lise, MD ; Nyman, Jan, MD ; Ramlau, Rodryg, MD ; Wickart-Johansson, Gun, MD ; Ellis, Peter, MD ; Gladkov, Oleg, MD ; Pereira, José Rodrigues, MD ; Eberhardt, Wilfried Ernst Erich, MD ; Helwig, Christoph, Dipl Stat ; Schröder, Andreas, MD ; Shepherd, Frances A, Prof

The lancet oncology, 2014, Vol.15 (1), p.59-68 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

Chen, Gang ; Umelo, Ijeoma Adaku ; Lv, Shasha ; Teugels, Erik ; Fostier, Karel ; Kronenberger, Peter ; Dewaele, Alex ; Sadones, Jan ; Geers, Caroline ; De Grève, Jacques Chellappan, Srikumar P.

PloS one, 2013-03, Vol.8 (3), p.e60317-e60317 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
9
Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer
Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer

Cousin, François ; Desir, Colin ; Ben Mustapha, Selma ; Mievis, Carole ; Coucke, Philippe ; Hustinx, Roland

Radiotherapy and oncology, 2021-04, Vol.157, p.47-55 [Periódico revisado por pares]

Ireland: Elsevier B.V

Texto completo disponível

Citações Citado por
10
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

Chen, Gang ; Kronenberger, Peter ; Teugels, Erik ; Umelo, Ijeoma Adaku ; De Grève, Jacques

BMC medicine, 2012-03, Vol.10 (1), p.28-28, Article 28 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (53.722)
  2. magazinearticle  (44)
  3. Anais de Congresso  (31)
  4. Reports  (13)
  5. Recursos Textuais  (5)
  6. Book Chapters  (4)
  7. Livros  (4)
  8. Web Resources  (3)
  9. Newsletter Articles  (2)
  10. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1973  (331)
  2. 1973Até1984  (1.516)
  3. 1985Até1996  (3.505)
  4. 1997Até2009  (12.557)
  5. Após 2009  (35.963)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (52.134)
  2. Japonês  (7.478)
  3. Chinês  (635)
  4. Francês  (418)
  5. Alemão  (256)
  6. Espanhol  (125)
  7. Português  (81)
  8. Russo  (65)
  9. Italiano  (55)
  10. Polonês  (41)
  11. Holandês  (39)
  12. Norueguês  (20)
  13. Dinamarquês  (19)
  14. Tcheco  (16)
  15. Húngaro  (12)
  16. Catalão  (10)
  17. Coreano  (9)
  18. Sueco  (9)
  19. Serbian  (8)
  20. Turco  (5)
  21. Indeterminado  (1)
  22. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Okoshi, M
  2. Bandarra, E
  3. Okoshi, K
  4. Corrêa, L
  5. Nobrega, M

Neste Assunto:

  1. Humans
  2. Science & Technology
  3. Life Sciences & Biomedicine
  4. Lung Neoplasms - Drug Therapy
  5. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.